Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2)

  1. Blanco, J.-R.
  2. Alejos, B.
  3. Moreno, S.
Revista:
PLoS ONE

ISSN: 1932-6203

Any de publicació: 2020

Volum: 15

Número: 1

Tipus: Article

DOI: 10.1371/JOURNAL.PONE.0226724 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus